Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Treat Rev. 2008 Dec;34(8):719-27. doi: 10.1016/j.ctrv.2008.06.001. Epub 2008 Jul 26.

Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.

Author information

1
Department of Radiation Oncology, University of Arizona, 1501 N. Campbell Avenue, Tucson, AZ, USA. NamPhong.Nguyen@yahoo.com

Abstract

Management of early stages non-small cell lung carcinoma has traditionally been surgery with radiation selected for medically inoperable patients. Recent emergence of stereotactic body radiation therapy allows for delivery of high radiation dose to the tumor while sparing normal lungs. This reviews compares loco-regional control, survival and complications rates between these two treatment modalities. Literature search identifies studies with stereotactic body radiation therapy and surgery for early stages non-small cell lung cancer. Effectiveness and toxicity of these two modalities was assessed. Stereotactic body radiation therapy is associated with minimal morbidity and provides comparable local control and survival in patients with multiple co-morbidities factors. Stereotactic body radiation therapy may become standard of care for operable early stages non-small cell lung cancer.

PMID:
18657910
DOI:
10.1016/j.ctrv.2008.06.001
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center